Zhangzhou Pientzehuang Pharmaceutical | Nettoeinkommen

Aktienkurs
156.20
Täglich Wechseln
-2.60 -1.64%
Monatlich
-4.69%
Jährlich
-22.44%
Q1 Prognose
156.11




Nettoeinkommen Veränderung Datum
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alaunos Therapeutics USD -1.16M 417K 2025-09
Avita Medical AUD -11.62M 1.7M 2025-12
Cspc Pharmaceutical CNY 963.54M 106.35M 2025-09
Dianthus Therapeutics USD -36.76M 5.13M 2025-09
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Jiangsu Hengrui CNY 1.3B 1.27B 2025-09
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Moderna USD -200M 625M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Sh Fosun Pharma CNY 821.33M 115.88M 2025-09
Tectonic Therapeutic USD -19.04M 940K 2025-09
Viatris USD -340.1M 211.9M 2025-12
Wuxi Apptec CNY 3.51B 1.39B 2025-09
Xeris Pharmaceuticals USD 621K 2.55M 2025-09
Zz Pientze Pharmaceu CNY 687.04M 244.51M 2025-09


Zhangzhou Pientzehuang Pharmaceutical Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.